Literature DB >> 25490692

MicroRNAs in the pathogenesis of cystic kidney disease.

Yu Leng Phua1, Jacqueline Ho.   

Abstract

PURPOSE OF REVIEW: Cystic kidney diseases are common renal disorders characterized by the formation of fluid-filled epithelial cysts in the kidneys. The progressive growth and expansion of the renal cysts replace existing renal tissue within the renal parenchyma, leading to reduced renal function. While several genes have been identified in association with inherited causes of cystic kidney disease, the molecular mechanisms that regulate these genes in the context of post-transcriptional regulation are still poorly understood. There is increasing evidence that microRNA (miRNA) dysregulation is associated with the pathogenesis of cystic kidney disease. RECENT
FINDINGS: In this review, recent studies that implicate dysregulation of miRNA expression in cystogenesis will be discussed. The relationship of specific miRNAs, such as the miR-17∼92 cluster and cystic kidney disease, miR-92a and von Hippel-Lindau syndrome, and alterations in LIN28-LET7 expression in Wilms tumor will be explored.
SUMMARY: At present, there are no specific treatments available for patients with cystic kidney disease. Understanding and identifying specific miRNAs involved in the pathogenesis of these disorders may have the potential to lead to the development of novel therapies and biomarkers.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25490692      PMCID: PMC4409326          DOI: 10.1097/MOP.0000000000000168

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  78 in total

1.  A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA.

Authors:  G Hutvágner; J McLachlan; A E Pasquinelli; E Bálint; T Tuschl; P D Zamore
Journal:  Science       Date:  2001-07-12       Impact factor: 47.728

2.  Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans.

Authors:  R F Ketting; S E Fischer; E Bernstein; T Sijen; G J Hannon; R H Plasterk
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

3.  The pro-apoptotic protein Bim is a microRNA target in kidney progenitors.

Authors:  Jacqueline Ho; Priyanka Pandey; Tobias Schatton; Sunder Sims-Lucas; Myda Khalid; Markus H Frank; Sunny Hartwig; Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2011-05-05       Impact factor: 10.121

4.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 5.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

6.  MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease.

Authors:  Seung-Ok Lee; Tatyana Masyuk; Patrick Splinter; Jesús M Banales; Anatoliy Masyuk; Angela Stroope; Nicholas Larusso
Journal:  J Clin Invest       Date:  2008-10-23       Impact factor: 14.808

7.  LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance.

Authors:  Melissa L Wilbert; Stephanie C Huelga; Katannya Kapeli; Thomas J Stark; Tiffany Y Liang; Stella X Chen; Bernice Y Yan; Jason L Nathanson; Kasey R Hutt; Michael T Lovci; Hilal Kazan; Anthony Q Vu; Katlin B Massirer; Quaid Morris; Shawn Hoon; Gene W Yeo
Journal:  Mol Cell       Date:  2012-09-06       Impact factor: 17.970

8.  Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella.

Authors:  G J Pazour; B L Dickert; Y Vucica; E S Seeley; J L Rosenbaum; G B Witman; D G Cole
Journal:  J Cell Biol       Date:  2000-10-30       Impact factor: 10.539

9.  miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease.

Authors:  Vishal Patel; Darren Williams; Sachin Hajarnis; Ryan Hunter; Marco Pontoglio; Stefan Somlo; Peter Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-12       Impact factor: 11.205

10.  Selective blockade of microRNA processing by Lin28.

Authors:  Srinivas R Viswanathan; George Q Daley; Richard I Gregory
Journal:  Science       Date:  2008-02-21       Impact factor: 47.728

View more
  6 in total

Review 1.  Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases.

Authors:  Kirti Bhatt; Mitsuo Kato; Rama Natarajan
Journal:  Am J Physiol Renal Physiol       Date:  2015-11-04

2.  Transcriptome-Wide Identification of miRNA Targets under Nitrogen Deficiency in Populus tomentosa Using Degradome Sequencing.

Authors:  Min Chen; Hai Bao; Qiuming Wu; Yanwei Wang
Journal:  Int J Mol Sci       Date:  2015-06-18       Impact factor: 5.923

3.  Renal stromal miRNAs are required for normal nephrogenesis and glomerular mesangial survival.

Authors:  Yu Leng Phua; Jessica Y S Chu; April K Marrone; Andrew J Bodnar; Sunder Sims-Lucas; Jacqueline Ho
Journal:  Physiol Rep       Date:  2015-10

4.  Six2creFrs2α knockout mice are a novel model of renal cystogenesis.

Authors:  Pawan Puri; Daniel Bushnell; Caitlin M Schaefer; Carlton M Bates
Journal:  Sci Rep       Date:  2016-11-17       Impact factor: 4.379

5.  Microarray analysis reveals gene and microRNA signatures in diabetic kidney disease.

Authors:  Chengji Cui; Yabin Cui; Yanyan Fu; Sichao Ma; Shoulin Zhang
Journal:  Mol Med Rep       Date:  2017-11-28       Impact factor: 2.952

6.  Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes.

Authors:  Yuan Cheng; Dandan Wang; Feng Wang; Jing Liu; Baorui Huang; Maria Angeles Baker; Jianyong Yin; Rui Wu; Xuanchen Liu; Kevin R Regner; Kristie Usa; Yong Liu; Congxiao Zhang; Lijin Dong; Aron M Geurts; Niansong Wang; Sheldon S Miller; Yongcheng He; Mingyu Liang
Journal:  J Am Soc Nephrol       Date:  2020-06-02       Impact factor: 14.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.